Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1328.35
27.05
(2.08%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr Reddys unveils Gemcitabine for Injection in US
>>
Dr Reddy's to buy JB Chem's drug portfolio for Rs 157 cr
>>
Dr Reddys lab reports 25% rise in its Q1 net profit
>>
Dr Reddy’s Laboratories gets USFDA approval for Fondaparinux Sodium Injection
>>
Dr Reddy’s launches Amlodipine Besylate and Benazepril Hydrochloride capsules
>>
USFDA bans Dr Reddy's Mexico plant’s drugs
>>
Dr Reddy's Mexican arm receives USFDA warning letter
>>
Dr Reddy’s Mexico facility gets USFDA warning letter
>>
Dr Reddy’s Lab launches three products in the US market
>>
Dr Reddy's polypill halves heart disease and stroke risk in trial
<<
<
139
140
141
...143
>
>>